EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Delineating genotype and parent‐of‐origin effect on the phenotype in MSH6 ‐associated Lynch syndrome

Anne-Sophie van der Werf-'t Lam, Mar Rodriguez-Girondo, Mandy Villasmil, Carli M Tops, Liselotte van Hest, Hans J P Gille, Floor A M Duijkers, Anja Wagner, Ellis Eikenboom, Tom G W Letteboer, Mirjam M de Jong, Sanne W Bajwa-Ten Broeke und 6 weitere

Genes, Chromosomes and Cancer · 2024

DOI: 10.1002/gcc.23237 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, Chromosomes and Cancer, 2024. Verfasst von Anne-Sophie van der Werf-'t Lam und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Hereditary Nonpolyposis, DNA-Binding Proteins, Phenotype, Genotype. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Maag Lever Darm Stichting.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study investigates the potential influence of genotype and parent‐of‐origin effects (POE) on the clinical manifestations of Lynch syndrome (LS) within families carrying (likely) disease‐causing MSH6 germline variants. Patients and Methods A cohort of 1615 MSH6 variant carriers (310 LS families) was analyzed. Participants were categorized based on RNA expression and parental inheritance of the variant. Hazard ratios (HRs) were calculated using weighted Cox regression, considering external information to address ascertainment bias. The findings were cross‐validated using the Prospective Lynch Syndrome Database (PLSD) for endometrial cancer (EC).

Results

No significant association was observed between genotype and colorectal cancer (CRC) risk (HR = 1.06, 95% confidence interval [CI]: 0.77–1.46). Patients lacking expected RNA expression exhibited a reduced risk of EC (Reference Cohort 1: HR = 0.68, 95% CI: 0.43–1.03; Reference Cohort 2: HR = 0.63, 95% CI: 0.46–0.87). However, these results could not be confirmed in the PLSD. Moreover, no association was found between POE and CRC risk (HR = 0.78, 95% CI: 0.52–1.17) or EC risk (Reference Cohort 1: HR = 0.93, 95% CI: 0.65–1.33; Reference Cohort 2: HR = 0.8, 95% CI: 0.64–1.19). Discussion and Conclusion No evidence of POE was detected in MSH6 families. While RNA expression may be linked to varying risks of EC, further investigation is required to explore this observation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal Neoplasms, Hereditary NonpolyposisDNA-Binding ProteinsPhenotypeGenotypeHumansFemaleMaleMiddle AgedAdultGerm-Line MutationAgedGenetic Predisposition to DiseaseEndometrial Neoplasms

Stichwörter der Autor:innen

Lynch syndromecancer riskscolorectal carcinomaendometrial carcinoma

Substanzen

G-T mismatch-binding proteinDNA-Binding Proteins

Autor:innen und Institutionen

  • Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.
  • Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, The Netherlands.
  • Department of Clinical Genetics, Amsterdam UMC, location Vrije Universiteit Amsterdam and location University of Amsterdam, Amsterdam, The Netherlands.
  • Department of Human Genetics, Amsterdam University Medical Center, location Amsterdam Medical Center, Amsterdam, The Netherlands.
  • Department of Clinical Genetics, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Department of Gastroenterology and Hepatology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.

ORCID-Profile: Maartje Nielsen

Förderung

  • Maag Lever Darm Stichting

Zitieren

APA

van der Werf-'t Lam, A. S., Rodriguez-Girondo, M., Villasmil, M., Tops, C. M., van Hest, L., Gille, H. J. P., Duijkers, F. A. M., Wagner, A., Eikenboom, E., Letteboer, T. G. W., de Jong, M. M., Bajwa-Ten Broeke, S. W., Bleeker, F., Gomez Garcia, E. B., Dominguez-Valentin, M., Møller, P., Suerink, M., & Nielsen, M. (2024). Delineating genotype and parent‐of‐origin effect on the phenotype in MSH6 ‐associated Lynch syndrome. Genes, Chromosomes and Cancer. https://doi.org/10.1002/gcc.23237

Vancouver

van der Werf-'t Lam AS, Rodriguez-Girondo M, Villasmil M, Tops CM, van Hest L, Gille HJP, et al. Delineating genotype and parent‐of‐origin effect on the phenotype in MSH6 ‐associated Lynch syndrome. Genes, Chromosomes and Cancer. 2024. doi:10.1002/gcc.23237

BibTeX
@article{vanderWerftLam2024,
  author = {van der Werf-'t Lam, Anne-Sophie and Rodriguez-Girondo, Mar and Villasmil, Mandy and Tops, Carli M and van Hest, Liselotte and Gille, Hans J P and Duijkers, Floor A M and Wagner, Anja and Eikenboom, Ellis and Letteboer, Tom G W and de Jong, Mirjam M and Bajwa-Ten Broeke, Sanne W and Bleeker, Fonnet and Gomez Garcia, Encarna B and Dominguez-Valentin, Mev and Møller, Pal and Suerink, Manon and Nielsen, Maartje},
  title = {Delineating genotype and parent‐of‐origin effect on the phenotype in MSH6 ‐associated Lynch syndrome},
  journal = {Genes, Chromosomes and Cancer},
  year = {2024},
  doi = {10.1002/gcc.23237}
}
Kostenlos starten →